🔎 Trials Near Me

Hem › Melanom › Wisconsin

Kliniska studier för Melanom i Wisconsin

20 studier för Melanom söker deltagare vid platser i Wisconsin.

Städer i Wisconsin

Officiell studietext (engelska)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • ThedaCare Regional Medical Center - Appleton, Appleton
  • och 50 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

  • UW Hospital and Clinics, Madison
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07281924

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Duluth Clinic Ashland, Ashland
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • och 17 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • University of Wisconsin Carbone Cancer Center, Madison
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06246916

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  • Marshfield Medical Center-Marshfield, Marshfield
  • Froedtert Menomonee Falls Hospital, Menomonee Falls
  • Medical College of Wisconsin, Milwaukee
  • och 4 fler
RekryterarFas 3
Ålder 75 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07068074

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0134, Madison
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Langlade Hospital and Cancer Center, Antigo
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • Gundersen Lutheran Medical Center, La Crosse
  • och 11 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • ThedaCare Regional Cancer Center, Appleton
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT05059444

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

  • University of Wisconsin-Madison Carbone Cancer Center, Madison
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07287917

Project: Every Child for Younger Patients With Cancer

  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
  • Marshfield Medical Center-Marshfield, Marshfield
  • och 1 fler
RekryterarObservationsstudie
Upp till ålder 25 · Alla kön · Uppdaterad 25 aug. 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • University of Wisconsin- Madison, Madison
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 aug. 2026 · NCT05592626

Integrated Cancer Repository for Cancer Research

  • Bellin Memorial Hospital, Green Bay
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 19 till 110 · Alla kön · Uppdaterad 29 juni 2026 · NCT02012699

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • University of Wisconsin Health, Madison
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 6 maj 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
RekryterarFas 2/3
Alla åldrar · Alla kön · Uppdaterad 2 apr. 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Aspirus Langlade Hospital, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • Ascension Saint Elizabeth Hospital, Appleton
  • och 61 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

  • University of Wisconsin Hospitals and Clinics (UWHC), Madison
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 20 jan. 2026 · NCT06199713

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Milwaukee
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

In Vivo Liquid Biopsy of Melanoma (Cytophone)

  • SSM Health Dean Medical Group Specialty Services, Madison
RekryterarFriska volontärer välkomna
Ålder 18 till 80 · Alla kön · Uppdaterad 11 mars 2025 · NCT06488365

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • University of Winsconsin Carbone Cancer Center-Eastpark medical Center, Madison
  • University of Wisconsin Carbone Cancer Center, Madison
  • Marshfield Medical Center - Marshfield, Marshfield
  • och 3 fler
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 27 nov. 2024 · NCT03860883

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.